Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?
C Fernández-de-las-Peñas, A Franco-Moreno… - Viruses, 2024 - mdpi.com
The aim of this study was to investigate the effects of administrating Remdesivir at the acute
COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 …
COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 …
Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease
CC Chen, CY Huang, JY Wu, MY Liu… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study examined the effectiveness of nirmatrelvir plus ritonavir (NMV-r) and
molnupiravir (MOV) in treating COVID-19 among chronic kidney disease (CKD) patients …
molnupiravir (MOV) in treating COVID-19 among chronic kidney disease (CKD) patients …
The importance of including Long COVID outcomes when developing novel treatments for acute COVID-19
C Connor, HA Taylor - The Journal of Infectious Diseases, 2024 - academic.oup.com
The ongoing COVID-19 pandemic continues to present surges in infections demonstrating
the persistent threat posed by COVID-19. Amidst efforts to develop effective treatments for …
the persistent threat posed by COVID-19. Amidst efforts to develop effective treatments for …
Malnutrition and the Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Multi-Institutional Population-Based Propensity Score …
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has led to a global health crisis, exacerbating issues like …
coronavirus 2 (SARS-CoV-2), has led to a global health crisis, exacerbating issues like …